CCIA
CLVS

Campbell & Co Investment Adviser’s Clovis Oncology, Inc. CLVS Stock Holding History

Campbell & Co Investment Adviser’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,102
Closed -$40K – 890
2019
Q3 		$40K Sell
10,102
-15,166
-60% -$123K 0.02% 584
2019
Q2 		$376K Buy
+25,268
New +$457K 0.17% 228

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Campbell & Co Investment Adviser's CLVS Position: Q4 2019 in Review

Campbell & Co Investment Adviser sold out of Clovis Oncology, Inc. (CLVS) in Q4 2019, closing a stake of 10,102 shares — an estimated $40K sold.

Campbell & Co Investment Adviser first reported a position in CLVS in Q2 2019 and held it in 2 quarters. The position peaked at $376K in Q2 2019. 147 funds tracked by Wall St. Rank hold CLVS as of Q4 2019.

  • Campbell & Co Investment Adviser reported no remaining Clovis Oncology, Inc. position as of Q4 2019 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 10,102 Clovis Oncology, Inc. shares in Q4 2019, an estimated $40K.
  • Campbell & Co Investment Adviser first reported a position in Clovis Oncology, Inc. in Q2 2019 and held it in 2 quarters.
  • Campbell & Co Investment Adviser's Clovis Oncology, Inc. position peaked at $376K in Q2 2019.
  • 147 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2019.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2019, filed 23 Jan 2020.